Status: Not yet recruiting
A Multicenter, Randomized, Double-blind, Placebo-parallel-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of HRS9531 Injection in Obese Subjects With Polycystic Ovary Syndrome
Randomized, double-blind, placebo-controlled study of HRS9531 in PCOS subjects
Participants needed: 144
Trial details
Phase: Phase 2Age: 18-40Biological sex: FemaleType: InterventionalSponsor: Fujian Shengdi Pharmaceutical Co., Ltd.Updated: Sep 19, 2024
Eligibility criteria
With my consent and signed informed consent, I am willing and able to complete t... [+5]
Endometrial biopsy is necessary as assessed by the investigators, and the pathol... [+26]